TCM product approved for sale in Singapore
By Zhang Yu in Shijiazhuang |
chinadaily.com.cn |
Updated: 2020-05-07 15:56
Share
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- World's tallest tower for gauging wind completed
- Heritage plan stresses digital tech, cooperation
- Shanghai airport opens exhibition of Asia's largest fin whale skeleton
- China's railway passenger trips hit record single-day high
- China's high-speed rail network expansion to facilitate cross-city collaboration
- A lifelong guardian of children's breath
